Zealand Pharma A/S EBITDA Margin 2018-2022 | ZEAL
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Zealand Pharma A/S (ZEAL) over the last 10 years. The current EBITDA margin for Zealand Pharma A/S as of March 31, 2022 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2022-03-31 | $0.04B | $-0.17B | -419.51% |
| 2021-12-31 | $0.05B | $-0.17B | -357.45% |
| 2021-09-30 | $0.05B | $-0.18B | -352.00% |
| 2021-06-30 | $0.04B | $-0.17B | -411.90% |
| 2021-03-31 | $0.06B | $-0.13B | -219.67% |
| 2020-12-31 | $0.06B | $-0.12B | -214.55% |
| 2020-09-30 | $0.05B | $-0.09B | -202.17% |
| 2020-06-30 | $0.04B | $-0.08B | -213.16% |
| 2020-03-31 | $0.01B | $-0.09B | -1175.00% |
| 2019-09-30 | $0.01B | $-0.08B | -1333.33% |
| 2018-12-31 | $0.01B | $0.10B | 1716.67% |
| 2018-06-30 | $0.01B | $-0.06B | -483.33% |
| 2018-03-31 | $0.01B | $-0.05B | -425.00% |
| 2017-12-31 | $0.02B | $-0.04B | -176.19% |
